Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Enecom, Inc., a Japanese ICT Services Provider, Enhances Its Enterprise Data Infrastructure with the InfiniBox® Solution for 100% Availability and Cyber Resilient Storage
-
Ascentage Pharma to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Provident Bank Announces New Hires and Promotions
-
Meritage Homes Fourth Quarter 2025 Earnings Conference Call and Webcast Scheduled for January 29, 2026
-
SAGA Metals Defines Key Structural Geology at Trapper South & Provides Corporate Update
-
VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement
-
Asia Broadband Corporate Update and Projects Status Scheduled For January 2026 and AABB Shareholders Merry Christmas
-
E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation
-
LifeSci Communications Promotes Ian Stone to Chief Executive Officer
-
DoubleDown Interactive Announces Pricing of Secondary Offering by Selling Shareholder
-
HUB Cyber Security (Nasdaq: HUBC) Announces First Half 2025 Results and Declares Its Strategic Mission: Build the Global Trust Infrastructure for the Digital Economy
-
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates
-
Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer
-
SharpLink Appoints Joseph Chalom as Sole CEO and Member of the Board; Rob Phythian Steps Down Following Company’s Planned Transition
-
The 2026 State of Performance Marketing Report: How Inflated Signals, AI Noise, and Disconnected Tools Are Derailing B2B Growth
-
CERo Therapeutics Provides Clinical Update on Phase 1 Clinical Trial of CER-1236 in AML (CertainT-1)
-
Locafy Reports Continued Commercial Growth as Localizer Adoption and Partner Results Build into CY 2026
-
SAB BIO Announces Positive Confirmatory Clinical Results from the Phase 1 Study of SAB-142 in Development for the Treatment of Stage 3 T1D
-
Gabelli Funds Now Offers Seven Fully Transparent ETF Strategies
-
Iterum Therapeutics Provides Business Update
-
Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Avalyn to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
CMO Council to Team With Chief Marketer Network on Strategic Thought Leadership Initiatives in 2026
-
Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Alignment Healthcare to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Rexel: Denial of rumors regarding Rexel acquisition
-
Cannabliss Innovates with Custom Packaging Solutions for the Cannabis Industry
-
Form 8.3 - 1Spatial Plc
-
Southern Michigan Bancorp, Inc. Declares Cash Dividend
-
Form 8.3 - Frenkel Topping Group Plc
-
Form 8.3 - Inspecs Group Plc
-
Jeffs’ Brands: KeepZone AI Successfully Completes Live Pilot Demonstrating Checkpoint-Free Weapon Screening at High-Profile Event
-
MiddleGround Capital Completes Sale of Lindsay Precast to TJC
-
Beyond Air® Signs New International LungFit PH® Distribution Agreements, Most Notably in Germany and Brazil
-
Cytokinetics Announces NMPA Approval of MYQORZO® (aficamten) in China for Patients with Obstructive Hypertrophic Cardiomyopathy
-
Alliance Police Department Commits to Non-Lethal Response with Full BolaWrap® 150 Rollout
-
Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference
-
Beneficient Appoints Peter T. Cangany Jr. as Chairman of the Board
-
NorthStrive Biosciences Advances to Phase III of AI-Driven Drug Discovery Program Toward Validation of Multiple Potential Drug Compounds & Discoveries
-
Valour Inc. Launches Constant Leveraged Bitcoin and Ethereum ETPs on Spotlight Stock Market
-
NorthStrive Biosciences Advances to Phase III of AI-Driven Drug Discovery Program Toward Validation of Multiple Potential Drug Compounds & Discoveries
-
Terra Innovatum Advances NRC Licensing of SOLO™ Reactor Licensing Through Expanded Regulatory Submissions
-
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
-
Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates
-
Bombardier Announces $500 Million Debt Repayment and Confirms Deleveraging Plan on Target
-
Renowned AI Expert Xi Chen Joins Compass Lexecon
-
Nayax Partners with Unipaas to Launch Fully Integrated Card-Present Payments Solution for UK SaaS Platforms
-
Unipaas Partners with Nayax to Launch Fully Integrated Card-Present Payments Solution for UK SaaS Platforms
-
Xeronum Emerges to Power the Next Wave of Digital Experiences
-
Kane Biotech Presents New Data at Innovations in Wound Healing Annual Meeting
